Begg, Malcolm <br/><br/>
Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase   [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  06 2019 
 - 443-453 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.119.257311  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adult<br/>Animals<br/>Bronchoalveolar Lavage<br/>Eosinophilia--drug therapy<br/>Female<br/>Humans<br/>Indazoles--administration & dosage<br/>Lung--metabolism<br/>Male<br/>Mice<br/>Middle Aged<br/>Permeability<br/>Phosphoinositide-3 Kinase Inhibitors--administration & dosage<br/>Safety<br/>Solubility<br/>Sputum--drug effects<br/>Sulfonamides--administration & dosage<br/>Translational Research, Biomedical